Copyright
©The Author(s) 2024.
World J Gastrointest Oncol. Jan 15, 2024; 16(1): 118-132
Published online Jan 15, 2024. doi: 10.4251/wjgo.v16.i1.118
Published online Jan 15, 2024. doi: 10.4251/wjgo.v16.i1.118
Table 3 Correlation between pSMAD3C(S423/425), TGF-β1 pSMAD3-S204 and VEGFR-1 expression in gastric cancer (n = 98)
| VEGFR-1 | pSMAD3-S425 | TGF-β1 | pSMAD3-S204 | |||||||||||||||
| - | + | ++ | +++ | r value | P value | - | + | ++ | +++ | r value | P value | - | + | ++ | +++ | r value | P value | |
| - | 0 | 10 | 3 | 0 | 0.302 | 0.002 | 0 | 8 | 5 | 0 | 0.22 | 0.029 | 1 | 10 | 1 | 1 | 0.201 | 0.047 |
| + | 3 | 12 | 11 | 1 | 1 | 8 | 15 | 3 | 4 | 18 | 5 | 0 | ||||||
| ++ | 2 | 20 | 22 | 6 | 2 | 14 | 32 | 2 | 6 | 24 | 14 | 6 | ||||||
| +++ | 0 | 1 | 5 | 2 | 0 | 1 | 4 | 3 | 1 | 3 | 3 | 1 | ||||||
- Citation: Lv SL, Guo P, Zou JR, Chen RS, Luo LY, Huang DQ. Prognostic significance and relationship of SMAD3 phospho-isoforms and VEGFR-1 in gastric cancer: A clinicopathological study. World J Gastrointest Oncol 2024; 16(1): 118-132
- URL: https://www.wjgnet.com/1948-5204/full/v16/i1/118.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v16.i1.118